Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience.

Vianello, A; Caminati, M; Andretta, M; Menti, A M; Tognella, S; Senna, G; Degli Esposti, L

Vianello, A; Caminati, M; Andretta, M; Menti, A M; Tognella, S; Senna, G; Degli Esposti, L.

Afiliación

Vianello A; Respiratory Pathophysiology Division, University-City Hospital of Padua, Padua, Italy.
Caminati M; Asthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy.
Andretta M; Department of Medicine, University of Verona, Verona, Italy.
Menti AM; Health Technology Assessment Unit, Azienda Zero, Padova, Italy.
Tognella S; Respiratory Unit, Orlandi General Hospital, Bussolengo, Verona, Italy.
Senna G; Asthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy.
Degli Esposti L; CliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy.

World Allergy Organ J ; 12(4): 100032, 2019.

Article en En | MEDLINE | ID: mdl-31193146

Palabras clave

Asthma; Asthma prevalence; Severe asthma; Treatment adherence

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: World Allergy Organ J Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google